Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?

Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?

The blood–brain barrier (BBB) is a barrier that separates the blood from the brain tissue and possesses unique characteristics that make the delivery of drugs to the brain a great challenge. To achieve this purpose, it is necessary to design strategies to allow BBB passage, in order to reach the bra...

Full description

Bibliographic Details
Main Authors:	Rúben G. R. Pinheiro, Ana Joyce Coutinho, Marina Pinheiro, Ana Rute Neves
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Series:	International Journal of Molecular Sciences
Subjects:	Alzheimer’s disease drug delivery drug targeting neurodegenerative diseases Parkinson’s disease
Online Access:	https://www.mdpi.com/1422-0067/22/21/11654

Similar Items

Mesoporous silica nanoparticles: Their potential as drug delivery carriers and nanoscavengers in Alzheimer's and Parkinson's diseases
by: Mohamed S. Attia, et al.
Published: (2023-03-01)

Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders
by: Mariano Catanesi, et al.
Published: (2021-01-01)

Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
by: Claudia Riccardi, et al.
Published: (2021-11-01)

Editorial: Traditional medicine and phytochemicals for neurodegenerative diseases treatment: application of interdisciplinary technologies in novel therapeutic target and drug discovery
by: Chuipu Cai, et al.
Published: (2023-08-01)

Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
by: Sarfaraz K. Niazi
Published: (2023-11-01)

Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting
by: Fabio Sonvico, et al.
Published: (2018-03-01)

Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders
by: Radka Boyuklieva, et al.
Published: (2022-07-01)

A Peptide-Based Nanocarrier for an Enhanced Delivery and Targeting of Flurbiprofen into the Brain for the Treatment of Alzheimer’s Disease: An In Vitro Study
by: Shafq Al-azzawi, et al.
Published: (2020-08-01)

Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches
by: Pedro Cruz-Vicente, et al.
Published: (2021-04-01)

Roles of Heme Oxygenase-1 in Neuroinflammation and Brain Disorders
by: Yi-Hsuan Wu, et al.
Published: (2022-05-01)

Formulation strategies for nose-to-brain drug delivery in Alzheimer's disease
by: Manisha Vohra, et al.
Published: (2023-03-01)

<i>Lactiplantibacillus (Lactobacillus) plantarum</i> as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature
by: Ana Isabel Beltrán-Velasco, et al.
Published: (2024-03-01)

Photobiomodulation for Neurodegenerative Diseases: A Scoping Review
by: Qi Shen, et al.
Published: (2024-01-01)

Paraoxonases at the Heart of Neurological Disorders
by: Fatimah K. Khalaf, et al.
Published: (2023-04-01)

Emerging drugs and targets for Alzheimer's disease /
by: Martn̕ez, Ana, 1961-, et al.
Published: (c201)

Recent progress in the intranasal PLGA-based drug delivery for neurodegenerative diseases treatment
by: Nasim Aghaei Delche, et al.
Published: (2023-10-01)

Neurodegenerative diseases and blood pressure variability: A comprehensive review from HOPE Asia
by: Yuda Turana, et al.
Published: (2022-09-01)

Role of Cholinergic Signaling in Alzheimer’s Disease
by: Zhi-Ru Chen, et al.
Published: (2022-03-01)

Nanotechnology Innovations to Enhance the Therapeutic Efficacy of Quercetin
by: Rúben G. R. Pinheiro, et al.
Published: (2021-10-01)

Does gut microbiota have an impact on the origin of Alzheimer's and Parkinson's disease? – literature review
by: Izabela Oleksak, et al.
Published: (2024-02-01)

Therapeutic effects of phlorotannins in the treatment of neurodegenerative disorders
by: Yoon Ji Kwon, et al.
Published: (2023-05-01)

Resveratrol: A potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction
by: Ekta Yadav, et al.
Published: (2022-09-01)

Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases
by: Dongmei Chen, et al.
Published: (2020-08-01)

Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases
by: Luis F. González, et al.
Published: (2021-12-01)

Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
by: Paras Mani Giri, et al.
Published: (2024-04-01)

Old Drugs as New Treatments for Neurodegenerative Diseases
by: Fernando Durães, et al.
Published: (2018-05-01)

Brain-inhabiting bacteria and neurodegenerative diseases: the “brain microbiome” theory
by: Tarek Ziad Arabi, et al.
Published: (2023-10-01)

Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects
by: Amarjitsing Rajput, et al.
Published: (2022-09-01)

Targeting Microbiota: What Do We Know about It at Present?
by: Aleksejs Derovs, et al.
Published: (2019-08-01)

PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases
by: Anthony Cunha, et al.
Published: (2021-07-01)

Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective
by: Dur E Nayab, et al.
Published: (2023-12-01)

Microbiome and Metabolome Insights into the Role of the Gastrointestinal–Brain Axis in Parkinson’s and Alzheimer’s Disease: Unveiling Potential Therapeutic Targets
by: Helena U. Zacharias, et al.
Published: (2022-12-01)

Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease
by: David Vicente-Zurdo, et al.
Published: (2022-06-01)

Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
by: Masaru Tanaka, et al.
Published: (2020-03-01)

Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development
by: Izabela Grabska-Kobyłecka, et al.
Published: (2023-08-01)

The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis
by: Simran Rastogi, et al.
Published: (2021-01-01)

The Emerging Role of Autophagy-Associated lncRNAs in the Pathogenesis of Neurodegenerative Diseases
by: Yapei Jiang, et al.
Published: (2023-06-01)

The Role of Impaired Mitochondrial Transport in the Development of Neurodegenerative Diseases
by: Alexander Blagov, et al.
Published: (2023-07-01)

Employing nanoparticle tracking analysis of salivary neuronal exosomes for early detection of neurodegenerative diseases
by: Vaibhav Sharma, et al.
Published: (2023-02-01)

Editorial: The underlying relationship between sleep and neurodegenerative diseases
by: Gerard Piñol-Ripoll, et al.
Published: (2023-01-01)